Difference between revisions of "Kanno H, et al. Int. J. Oncol. (2013) cited as Ref 323 in DOI: 10.1038/s41392-020-0110-5 (Q9586)"
Jump to navigation
Jump to search
(Created claim: Fourth Author string (P152): Yoshizumi T, #quickstatements; #temporary_batch_1590155310798) |
(Created claim: Fifth Author string (P153): Yamada S, #quickstatements; #temporary_batch_1590155508986) |
||
| Property / Fifth Author string | |||
| + | Yamada S | ||
| Property / Fifth Author string: Yamada S / rank | |||
| + | Normal rank | ||
Latest revision as of 13:52, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Kanno H, et al. Int. J. Oncol. (2013) cited as Ref 323 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Kanno H
0 references
Sato H
0 references
Yokoyama TA
0 references
2013
0 references
Int. J. Oncol.
0 references
42
0 references
The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway (English)
0 references
881-886
0 references
Yoshizumi T
0 references
Yamada S
0 references
